Burosumab-twza Subcutaneous and Insulin degludec and liraglutide
Determining the interaction of Burosumab-twza Subcutaneous and Insulin degludec and liraglutide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin Degludec and Liraglutide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Insulin degludec and liraglutide Subcutaneous
- Burosumab-twza Subcutaneous-Insulin degludec Subcutaneous
- Burosumab-twza Subcutaneous-Insulin detemir
- Burosumab-twza Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Burosumab-twza Subcutaneous-Insulin Detemir (Vials)
- Burosumab-twza Subcutaneous-Insulin detemir Subcutaneous
- Insulin degludec and liraglutide-Buspar
- Insulin degludec and liraglutide-Buspar Dividose
- Insulin degludec and liraglutide-Buspirone
- Insulin degludec and liraglutide-Buspirone Hydrochloride
- Insulin degludec and liraglutide-Busulfan
- Insulin degludec and liraglutide-Busulfan Concentrate Injection